1. General mechanism for the biological activation of quinone anticancer agents to free radicals;Bachur,1978
2. Belt, R.S., Himmelstein, K.J., Patton, T.F., Bannister, S.J., Sternson, L.A., Repta, A.J.: Pharmacokinetics of non-protein bound platinum species following administration of cis-dichlorodiammineplatinum(II). Cancer Treat. Rep. (to be published).
3. Therapeutic potentiation in a mouse mammary tumor and an intracerebral rat brain tumor by combined treatment with cis-dichlorodiammine-platinum(II) and radiation;Douple;J. Clin. Hernatol. Oncol.,1977
4. Analog comparison, combination chemotherapy, and combined modality studies with cis-platinum(II)-diamminedichloride (NSC 119875) using in vivo animal tumor models;Merker;J. Clin. Hematol. Oncol.,1977
5. Platinum compounds in clinical oncology: review and future prospects;Muggia,1978